Health

Merck Ends COVID Vaccine Program, Cites Inferior Immune Responses

merck-ends-covid-vaccine-program,-cites-inferior-immune-responses

The drugmaker will instead focus pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected by the end of March.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Health